HIV-Specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by igg antibodies

Journal of Virology

Volumn 85, Issue 18, 2011, Pages 9555-9567

  Fouda, Genevieve G ^a   Yates, Nicole L ^a   Pollara, Justin ^a   Shen, Xiaoying ^a   Overman, Glenn R ^a   Mahlokozera, Tatenda ^b   Wilks, Andrew B ^b   Kang, Helen H ^b   Salazar Gonzalez, Jesus F ^c   Salazar, Maria G ^c   Kalilani, Linda ^d   Meshnick, Steve R ^e   Hahn, Beatrice H ^c   Shaw, George M ^c   Lovingood, Rachel V ^a   Denny, Thomas N ^a   Haynes, Barton ^a   Letvin, Norman L ^b   Ferrari, Guido ^a   Montefiori, David C ^a   Tomaras, Georgia D ^a   Permar, Sallie R ^b,f   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF MALAWI   (Malawi)

^e IL   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY ISOLATION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BLOOD ANALYSIS; BREAST MILK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; MILK LEVEL; PRIORITY JOURNAL; PROTEIN BINDING; SEROPREVALENCE; VIRION; VIRUS LOAD; VIRUS NEUTRALIZATION;

ANTIBODIES, NEUTRALIZING; ANTIBODY FORMATION; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CROSS REACTIONS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MILK, HUMAN; NEUTRALIZATION TESTS; PLASMA;

EID: 80052463165     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05174-11     Document Type: Article

References (73)

1. Anonymous. 2000. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Lancet 355:451-455.
2. Banks, N. D., N. Kinsey, J. Clements, and J. E. Hildreth. 2002. Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS. AIDS Res. Hum. Retroviruses 18:1197-1205.
3. Barin, F., et al. 2006. Revisiting the role of neutralizing antibodies in motherto-child transmission of HIV-1. J. Infect. Dis. 193:1504-1511.
4. Becquart, P., et al. 1999. Compartmentalization of the IgG immune response to HIV-1 in breast milk. AIDS 13:1323-1331.
5. Becquart, P., et al. 2000. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J. Infect. Dis. 181:532-539.
6. Broliden, K., et al. 2001. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Immunol. Lett. 79:29-36.
7. Chasela, C. S., et al. 2010. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N. Engl. J. Med. 362:2271-2281.
8. Clerici, M., et al. 2002. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS 16:1731-1741.
9. Coovadia, H. M., et al. 2007. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 369:1107-1116.
10. Devito, C., et al. 2002. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J. Acquir. Immune Defic. Syndr. 30:413-420.
11. Dickover, R., et al. 2006. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants. J. Virol. 80:6525-6536.
12. Dorrell, L., et al. 2000. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS 14:1117-1122.
13. Farquhar, C., et al. 2008. Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya. Clin. Exp. Immunol. 153:37-43.
14. Ferrantelli, F., et al. 2007. Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques. Virology 358:69-78.
15. Fishaut, M., D. Murphy, M. Neifert, K. McIntosh, and P. L. Ogra. 1981. Bronchomammary axis in the immune response to respiratory syncytial virus. J. Pediatr. 99:186-191.
16. Florese, R. H., et al. 2006. Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge. J. Immunol. 177:4028-4036.
17. Forthal, D. N., G. Landucci, and B. Keenan. 2001. Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4 lymphocyte count. AIDS Res. Hum. Retroviruses 17:553-561.
18. Gao, F., et al. 2005. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group M consensus envelope glycoprotein. J. Virol. 79:1154-1163.
19. Hanson, L. A., et al. 1984. The immune response of the mammary gland and its significance for the neonate. Ann. Allergy 53:576-582.
20. Hanson, L. A., et al. 2003. The transfer of immunity from mother to child. Ann. N. Y. Acad. Sci. 987:199-206.
21. Hessell, A. J., et al. 2007. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449:101-104.
22. Hirbod, T., et al. 2008. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 22:727-735.
23. Hladik, F., and T. J. Hope. 2009. HIV infection of the genital mucosa in women. Curr. HIV/AIDS Rep. 6:20-28.
24. Hocini, H., and M. Bomsel. 1999. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J. Infect. Dis. 179(Suppl. 3):S448-S453.
25. John, G. C., et al. 2001. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J. Infect. Dis. 183:206-212.
26. Johnson, V. A., and R. E. Byington. 1990. Infectivity assay (virus yield assay), p. 71-76. In A. Aldovani and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York, NY.
27. Kaul, R., et al. 2001. Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection. AIDS 15:431-432.
28. Keele, B. F., et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557.
29. Kothe, D. L., et al. 2006. Ancestral and consensus envelope immunogens for HIV-1 subtype C. Virology 352:438-449.
30. Kozlowski, P. A., D. Chen, J. H. Eldridge, and S. Jackson. 1994. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals. AIDS Res. Hum. Retroviruses 10:813-822.
31. Kuhn, L., et al. 2006. HIV-specific secretory IgA in breast milk of HIVpositive mothers is not associated with protection against HIV transmission among breast-fed infants. J. Pediatr. 149:611-616.
32. Li, M., et al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccineelicited neutralizing antibodies. J. Virol. 79:10108-10125.
33. Lynch, J. B., et al. 16 March 2011. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies does not correlate with risk of infant infection. J. Virol. doi:10.1128/JVI.02216-10.
34. Mantis, N. J., et al. 2007. Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. J. Immunol. 179:3144-3152.
35. Mestecky, J., et al. 2004. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res. Hum. Retroviruses 20:972-988.
36. Mestecky, J., Z. Moldoveanu, P. D. Smith, Z. Hel, and R. C. Alexander. 2009. Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection. J. Reprod. Immunol. 83:196-200.
37. Mestecky, J., et al. 22 November 2010. Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women. AIDS Res. Hum. Retroviruses. doi:10.1089/aid.2010.0169.
38. Moja, P., et al. 2000. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J. Infect. Dis. 181:1607-1613.
39. Montefiori, D. C. 2009. Measuring HIV neutralization in a luciferase reporter gene assay. Methods Mol. Biol. 485:395-405.
40. Muster, T., et al. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642-6647.
41. Nag, P., et al. 2004. Women with cervicovaginal antibody-dependent cellmediated cytotoxicity have lower genital HIV-1 RNA loads. J. Infect. Dis. 190:1970-1978.
42. Nduati, R., et al. 2000. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283:1167-1174.
43. Nguyen, M., et al. 2006. HIV-specific antibodies but not T-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia. J. Acquir. Immune Defic. Syndr. 42:412-419.
44. Nikolayenko, I. V., O. Galkin, N. I. Grabchenko, and M. Spivak. 2005. Preparation of highly purified human IgG, IgM, and IgA for immunization and immunoanalysis. Ukrainica Bioorganica Acta 2:3-11.
45. Permar, S. R., et al. 2010. Limited contribution of mucosal IgA to simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys. J. Virol. 84:8209-8218.
46. Pollara, J., et. al. 2011. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry A 79:603-612.
47. Polonis, V. R., et al. 2008. Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology 375:315-320.
48. Rahman, M. M., M. Yamauchi, N. Hanada, K. Nishikawa, and T. Morishima. 1987. Local production of rotavirus specific IgA in breast tissue and transfer to neonates. Arch. Dis. Child. 62:401-405.
49. Rainwater, S. M., et al. 2007. Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding. Curr. HIV Res. 5:189-197.
50. Raux, M., et al. 1999. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res. Hum. Retroviruses 15:1365-1376.
51. Richman, D. D., T. Wrin, S. J. Little, and C. J. Petropoulos. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U. S. A. 100:4144-4149.
52. Rousseau, C. M., et al. 2003. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J. Infect. Dis. 187:741-747.
53. Rousseau, C. M., et al. 2004. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J. Infect. Dis. 190:1880- 1888.
54. Ruprecht, R. M., et al. 2001. Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies. Transfus. Clin. Biol. 8:350-358.
55. Rychert, J., and A. M. Amedee. 2005. The antibody response to SIV in lactating rhesus macaques. J. Acquir. Immune Defic. Syndr. 38:135-141.
56. Salazar-Gonzalez, J. F., et al. 2011. Origin and evolution of HIV-1 in breast milk determined by single genome amplification and sequencing. J. Virol. 85:2751-2763.
57. Scarlatti, G., et al. 1993. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168:207-210.
58. Seaman, M. S., et al. 2010. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol. 84: 1439-1452.
59. Shapiro, R. L., et al. 2010. Antiretroviral regimens in pregnancy and breastfeeding in Botswana. N. Engl. J. Med. 362:2282-2294.
60. Söderlund, J., T. Hirbod, L. E. Goh, J. Andersson, and K. K. Broliden. 2004. Presence of HIV-1 neutralizing IgA antibodies in primary HIV-1 infected patients. Scand. J. Infect. Dis. 36:663-669.
61. Telemo, E., and L. A. Hanson. 1996. Antibodies in milk. J. Mammary Gland Biol. Neoplasia 1:243-249.
62. Tomaras, G. D., et al. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463.
63. Trkola, A., et al. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
64. Tuaillon, E., D. Valea, P. Becquart, Y. Tabaa, N. Meda, K. Bollore, P. Van de Perre, and J. P. Vendrell. 2009. Human milk-derived B cells: a highly activated switched memory cell population primed to secrete antibodies. J. Immunol. 182:7155-7162.
65. Van de Perre, P., D. G. Hitimana, and P. Lepage. 1988. Human immunodeficiency virus antibodies of IgG, IgA, and IgM subclasses in milk of seropositive mothers. J. Pediatr. 113:1039-1041.
66. Van de Perre, P., et al. 1993. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 341:914-918.
67. Wahl, S. M., et al. 1997. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis. 3(Suppl. 1):S64-S69.
68. Wei, X., et al. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.
69. WHO. 2010. PMTCT strategic vision 2010-2015: preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals. WHO Press, Geneva, Switzerland.
70. Williamson, C., et al. 2003. Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res. Hum. Retroviruses 19:133-144.
71. Wu, X., S. Hall, and S. Jackson. 2003. Tropism-restricted neutralization by secretory IgA from parotid saliva of HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses 19:275-281.
72. Xiao, P., et al. 2010. Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J. Virol. 84:7161-7173.
73. Yates, N. L., et al. 2009. HIV frequently elicits mucosal and plasma Envspecific IgA with a rapid initial decline in acute infection. J. Acquir. Immune Defic. Syndr. 51. doi:10.1097/01.qai.0000351099.78513.42.